Last edition
News about "Phase 3 study"
Mirum's Brelovitug Meets Phase 3 Endpoint in Chronic Hepatitis Delta
Mirum Pharmaceuticals reports positive Phase 3 AZURE-1 results for brelovitug, with the investigational antibody meeting its primary endpoint in chronic HDV.
Phase 3 Study | 29/09/2026 | By News Bureau
Astellas Advances Setidegrasib Into Phase 3 Trial for NSCLC
Astellas has dosed the first patient in a Phase 3 study evaluating setidegrasib against docetaxel in patients with KRAS G12D-mutated NSCLC.
Phase 3 Study | 25/09/2026 | By News Bureau | 131
Eli Lilly and Company's Ebglyss Shows Four-Year Durable Relief in Atopic Dermatitis Study
Long-term phase III data reveal sustained skin clearance and itch reduction with once-monthly dosing in eczema patients.
Phase 3 Study | 30/03/2026 | By News Bureau | 175
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy